Abstract |
Bioactivity guided phytochemical investigation led to isolation of six undescribed furostanol saponins, furoasparoside A-F along with five known compounds, gallic acid, methyl gallate, quercetin-3-O-β-glucopyranoside, liquiritigenin 4׳-O-β-apiofuranosyl-(1 → 2)-β-glucopyranoside and β- glucogallin for the first time from the roots of Asparagus racemosus. Isolated saponins were screened for their antidiabetic potential in L6-GLUT4myc myotubes in vitro followed by an in vivo evaluation in streptozocin-induced diabetic rats and db/db mice. Furoasparoside E produced a notable decrease in the postprandial blood glucose profile, in leptin receptor-deficient db/db mice, type 2 diabetes model. The effect of furoasparoside E on GLUT4 translocation was found to be mediated by the AMPK-dependent signaling pathway in L6-GLUT4myc myotubes. Moreover, it emerged as a stable plant metabolite with higher bioavailability and efficacy in in vivo pharmacokinetic studies. Therefore, these studies indicated that furoasparoside E may serve as a propitious lead for the management of type 2 diabetes and its secondary complications from natural source.
|
Authors | Alka Raj Pandey, Shadab Ahmad, Suriya Pratap Singh, Anjali Mishra, Amol Chhatrapati Bisen, Gaurav Sharma, Ishbal Ahmad, Sanjeev K Shukla, Rabi Sankar Bhatta, Sanjeev Kanojiya, Akhilesh Kumar Tamrakar, Koneni V Sashidhara |
Journal | Phytochemistry
(Phytochemistry)
Vol. 201
Pg. 113286
(Sep 2022)
ISSN: 1873-3700 [Electronic] England |
PMID | 35752344
(Publication Type: Journal Article)
|
Copyright | Copyright © 2022 Elsevier Ltd. All rights reserved. |
Chemical References |
- Blood Glucose
- Hypoglycemic Agents
- Saponins
|
Topics |
- Animals
- Asparagus Plant
(chemistry, metabolism)
- Blood Glucose
(metabolism)
- Diabetes Mellitus, Experimental
(drug therapy, metabolism)
- Diabetes Mellitus, Type 2
(drug therapy)
- Hypoglycemic Agents
(chemistry, pharmacology)
- Mice
- Rats
- Saponins
(chemistry, pharmacology)
|